Long-Term Predictors of Mortality After Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents
William McLeish Wilson, Nick Andrianopoulos, David Clark, Stephen James Duffy, Angela Brennan, Iwan Harries, Gishel New, Martin Sebastian, Philippa Loane, Christopher Reid, Andrew Edward Ajani
The American Journal of Cardiology | EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC | Published : 2011
The Melbourne Interventional Group acknowledges unrestricted educational grant funding from Abbott Vascular, Abbott Australasia Pty Ltd, Pharmaceuticals, Nutritionals and EAS, NSW, Australia, Astra-Zeneca, NSW, Australia, Biotronik, NSW, Australia, Boston-Scientific, NSW, Australia, Bristol-Myers Squibb, Victoria, Australia, CSL, Victoria, Australia, Johnson & Johnson, NSW, Australia, Medtronic, Melbourne, Australia, Pfizer, NSW, Australia, Schering-Plough, NSW, Australia, Sanofi-Aventis, NSW, Australia, Servier, Victoria, Australia. Dr. Dufty's work is supported by a grant from the National Health and Medical Research Council of Australia.